+852 2675 0230
News

Bright Future subsidiary, BF Suma, awarded ISO 22716 Good Manufacturing Practice certificate for Cosmetics in US

2020-02-24


Bright Future subsidiary BF Suma Pharmaceuticals Inc. was recently certified with ISO 22716 – Cosmetics Good Manufacturing Practices in the US. This is the first step in the ‘S100’ strategy (100% Skin Care Satisfaction) for entering the cosmetics sector, and highlights the company’s determination to have a global impact in the skincare sector. With new, first-rate facilities, Bright Future can now utilize its industry-leading expertise and technology to provide a large variety of skincare products, such as lotions, creams, essences, toners and facial masks.


Emphasis on global quality standards is and always has been a top priority for the company, hence Bright Future has aligned in this important direction to exceed their customers’ expectations.  Mike Ma, Vice President of Manufacturing and Supply at Bright Future said: “We are extremely proud of this new US GMP-standard production line which highlights the company’s high manufacturing standards and drive for excellence across its operations. This affirms Bright Future’s ambitious S100 Strategy, diversifying the business based on the advantage of our pharmaceutical background, so as to seek new points of growth in future development.”


ISO 22716:2007 is an international standard for Good Manufacturing Practices (GMP) for the cosmetics industry. It provides guidelines covering production, packaging, testing, storage and delivery for consistently ensuring high-quality and reliably safe cosmetic products.

BF Suma subsidiary Lonix awarded ISO 22716 Cosmetics GMP



Lonix factory



Copyright @ 2016 Bright Future Pharmaceutical Laboratories Limited. All Rights Reserved.